When it comes to detecting cancer, you want the fastest detection possible in order to treat it accurately and in a timely ...
Several rumors and speculations surrounding President Donald Trump‘s health have circulated ever since his second term began in 2025. However, now there are concerns about his predecessor – former ...
Steven Daniel, a prostate cancer warrior, talks about the importance of paying attention to your body and advocating for ...
In the real-world, Pluvicto™ showed 13.5 months median PFS in chemo-naïve patients with PSMA-positive mCRPC; Real‑world evidence showed Pluvicto achieved longer PFS when init ...
What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and providers in The Beam, published monthly.
Ahead of National Marriage Week, This is How We Do It singer Montell Jordan and his wife, Kristin, opened up about health, faith, marriage and family ...
More than 70% of patients with biochemically recurrent prostate cancer remained metastasis-free 5 years after PSMA PET/CT-guided salvage radiation therapy. Whole-pelvis radiation significantly ...
New research appearing in the Journal of the National Comprehensive Cancer Network found that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans may be able to ...
Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment. A recent ...
To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care necessary in the follow-up journey, Mayo Clinic's Department of Radiation ...
Reliable information and advocacy efforts empower kidney cancer patients to engage in research and treatment decisions. Pluvicto's FDA approval provides a new treatment for PSMA-positive metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results